These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 7571476

  • 1. [24-hour effectiveness and tolerance of perindopril (Prestarium), an ACE inhibitor, in the treatment of mild to moderate hypertension. A 1-year Czech and Slovak study].
    Widimský J, Fedelesová V, Uhlír O.
    Vnitr Lek; 1995 Jul; 41(7):441-4. PubMed ID: 7571476
    [Abstract] [Full Text] [Related]

  • 2. [24-hour effect and tolerance for perindopril (Prestarium) in mild and moderate essential hypertension].
    Widimský J, Cihák R, Fedelesová V, Lefflerová K, Mayer O, Uhlír O.
    Vnitr Lek; 1992 Nov; 38(11):1066-71. PubMed ID: 1494869
    [Abstract] [Full Text] [Related]

  • 3. A double blind comparison of perindopril and atenolol in essential hypertension.
    Thurston H, Mimran A, Zanchetti A, Creytens G, Rorive G, Brown CL, Santoni JP.
    J Hum Hypertens; 1990 Oct; 4(5):547-52. PubMed ID: 2283644
    [Abstract] [Full Text] [Related]

  • 4. [Spirapril in the therapy of mild and moderately severe hypertension. A Czech and Slovak multicenter study].
    Widimský J, Lánská V, Hulínský V.
    Vnitr Lek; 1995 Nov; 41(11):744-52. PubMed ID: 8553592
    [Abstract] [Full Text] [Related]

  • 5. Perindopril plus nifedipine versus perindopril plus hydrochlorothiazide in mild to severe hypertension: a double-blind multicentre study. The Multicentre Study Group on Treatment Association with Perindopril.
    Letellier P, Overlack A, Agnes E, Desche P.
    J Hum Hypertens; 1994 Feb; 8(2):145-9. PubMed ID: 8207741
    [Abstract] [Full Text] [Related]

  • 6. [The role of home pressure monitoring in the treatment hypertension in the practice of general medicine].
    Widimský J, Balazovjech I, Lánská V.
    Vnitr Lek; 1999 Oct; 45(10):569-77. PubMed ID: 10951863
    [Abstract] [Full Text] [Related]

  • 7. Efficacy and acceptability of perindopril in essential hypertension.
    Sukonthasarn A, Ratanaprakarn R, Koanantakul B, Ngam-Ukos P.
    J Med Assoc Thai; 1994 Jun; 77(6):281-7. PubMed ID: 7869013
    [Abstract] [Full Text] [Related]

  • 8. [The TEAM study--a study of the effectiveness and tolerance of treatment of essential hypertension with a fixed combination of trandolapril and verapamil].
    Widimský J, Dzúrik R.
    Vnitr Lek; 1998 Jun; 44(6):326-31. PubMed ID: 9820054
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Treatment of essential hypertension in general practice: an open-label study of 47,351 French hypertensive patients treated for one year with perindopril.
    Poggi L, Renucci JF, Denolle T.
    Can J Cardiol; 1994 Nov; 10 Suppl D():21D-24D. PubMed ID: 7954035
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Value of angiotensin converting enzyme inhibitors in the elderly: the example of perindopril.
    Forette F, McClaran J, Delesalle MC, Hervy MP, Bouchacourt P, Henry-Amar M, Santoni JP.
    Clin Exp Hypertens A; 1989 Nov; 11 Suppl 2():587-603. PubMed ID: 2691131
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Once daily perindopril versus slow release diltiazem in the treatment of mild to moderate essential hypertension. Canadian Study Group on Perindopril.
    Can J Cardiol; 1994 Nov; 10 Suppl D():8D-12D. PubMed ID: 7954041
    [Abstract] [Full Text] [Related]

  • 15. Evaluation of the efficacy and tolerability of the combination delapril plus indapamide in the treatment of mild to moderate essential hypertension: a randomised, multicentre, controlled study.
    Rosei EA, Rizzoni D, DIMS II (Delapril-Indapamide Multicenter Study II).
    J Hum Hypertens; 2003 Feb; 17(2):139-46. PubMed ID: 12574793
    [Abstract] [Full Text] [Related]

  • 16. Effects of perindopril on elastic and structural properties of large arteries in essential hypertension.
    Lacourcière Y, Béliveau R, Conter HS, Burgess ED, Lepage S, Pesant Y, Spence JD, Asmar R, Carrière S, Plante GE, Canadian Hypertension Society.
    Can J Cardiol; 2004 Jun; 20(8):795-9. PubMed ID: 15229761
    [Abstract] [Full Text] [Related]

  • 17. [Long-term decrease of microalbuminuria after one year of treatment with perindopril in hypertensive diabetic patients].
    Brichard SM, Santoni JP, Thomas JR, Van de Voorde K, Ketelslegers JM, Lambert AE.
    Ann Cardiol Angeiol (Paris); 1990 Oct; 39(8):495-9. PubMed ID: 2281920
    [Abstract] [Full Text] [Related]

  • 18. A comparison of valsartan and perindopril in the treatment of essential hypertension in the malaysian population.
    Bavanandan S, Morad Z, Ismail O, Chandran A, Thayaparan T, Singaraveloo M.
    Med J Malaysia; 2005 Jun; 60(2):158-62. PubMed ID: 16114156
    [Abstract] [Full Text] [Related]

  • 19. [Ambulatory registration of arterial pressure during treatment with perindopril. Effects on systolic pressure and hemodynamic implications].
    Santoni JP, Asmar RG, Bizot-Espiard JG, Safar M.
    Arch Mal Coeur Vaiss; 1989 May; 82 Spec No 1():51-6. PubMed ID: 2505713
    [Abstract] [Full Text] [Related]

  • 20. Therapeutic safety of perindopril in the treatment of mild hypertension with concomitant nephropathy.
    Bönner G, Lederle RM, Scholze J, Stumpe KO.
    Arzneimittelforschung; 1993 Aug; 43(8):852-5. PubMed ID: 8216441
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.